2007
DOI: 10.1016/j.jmb.2007.09.083
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Analysis of the HIV-1 Resistance Development: Enzymatic Activities, Crystal Structures, and Thermodynamics of Nelfinavir-resistant HIV Protease Mutants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
55
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 78 publications
(58 citation statements)
references
References 48 publications
3
55
0
Order By: Relevance
“…We also showed that D30 not only is key for inhibitor binding but also is essential for recognition of the p1-p6 cleavage site (8,15,22). Consequently, the D30N mutation, which lowers affinity for NFV (23), also likely compromises p1-p6 recognition, leading to coevolution of this cleavage site (15). Such p1-p6 cleavage site mutations commonly observed with D30N/N88D PR are L449F, S451N, and P453L (14), and they may help restoring the fit of the substrate in the consensus substrate envelope (24).…”
Section: H Uman Immunodeficiency Virus Type 1 (Hiv-1) Protease (Pr)mentioning
confidence: 76%
“…We also showed that D30 not only is key for inhibitor binding but also is essential for recognition of the p1-p6 cleavage site (8,15,22). Consequently, the D30N mutation, which lowers affinity for NFV (23), also likely compromises p1-p6 recognition, leading to coevolution of this cleavage site (15). Such p1-p6 cleavage site mutations commonly observed with D30N/N88D PR are L449F, S451N, and P453L (14), and they may help restoring the fit of the substrate in the consensus substrate envelope (24).…”
Section: H Uman Immunodeficiency Virus Type 1 (Hiv-1) Protease (Pr)mentioning
confidence: 76%
“…Therefore, a huge number of experimental studies in the fields of molecular biology, biochemistry and biophysics have been performed since the AIDS pandemics burst out which contributed to revealing the structure and enzymological properties of the enzyme. As a result of this effort, nine inhibitors have been brought to the stage of commercially produced and therapeutically used drugs during this period 1,2 .…”
Section: Introductionmentioning
confidence: 99%
“…On the contrary, several X-ray crystal structures of PR complexed with more asymmetric FDAapproved inhibitors, like darunavir, nelfinavir, and saquinavir (SQV), have the catalytic site occupied by the inhibitor oriented in two almost equivalent positions related by a pseudo-2-fold symmetry. [7][8][9][10][11][12] To investigate this order/disorder phenomenon and its possible relationship with crystal packing, we have undertaken a systematic search for new crystal forms of wild-type PR in complex with SQV. Single crystals of the PR/SQV complex were obtained by a vapor diffusion technique and analyzed by X-ray diffraction.…”
mentioning
confidence: 99%